Updated:
SteadyMed Ltd.
SteadyMed Ltd. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001619087, and its reported industry is...
Overview
SteadyMed Ltd. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001619087, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2018-03-30, it reported annual revenue of USD 1,065,000; net income of USD -23,205,000; total assets of USD 38,491,000 for the fiscal period ended 2017-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- SteadyMed Ltd.
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Rehovot, Israel
- Incorporated in
- L3
- Fiscal year end
- December 31
- SEC CIK
- 0001619087
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2017USD | $1.1M | -$23.2M | $38.5M | $32.5M | -$22.2M | |
| FY2016USD | $1.1M | -$25.9M | $28.2M | $23.2M | — | |
| FY2015USD | $869,000 | -$25.0M | $35.2M | $31.9M | — |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| SC 13G | — | Form SC 13G | |
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| SC 13G | — | Form SC 13G | |
| SC 13D | — | SC 13D | |
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research SteadyMed Ltd. in Altss
Track this company’s investors, transactions and relationships in Altss.